Treating allergic rhinitis in a managed care environment.
Lynch
Judith Shannon
JS
ENT Associates of Waterbury, Conn , USA.
D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D017281:Cost of Illness; D003888:Desensitization, Immunologic; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D019458:Insurance Coverage; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D008329:Managed Care Programs / Q000458:organization & administration*; D014663:Nasal Decongestants / Q000627:therapeutic use; D009722:Nurse Practitioners / Q000458:organization & administration*; D009730:Nursing Assessment; D010347:Patient Care Planning; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000458:organization & administration; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000628:therapy*
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D006633:Histamine Antagonists; D020024:Leukotriene Antagonists; D014663:Nasal Decongestants